I'll leave share price predictions to others, I do
Post# of 148153
With that said, I will be pretty surprised if our results arent positive. There is a chance that we show a sizable reduction in mortality, but just miss the PE. If we do, most of us still expect an EUA.
My belief is that we will show a large enough reduction to meet the p value, but we will see.
RLFTF is on the verge of their data as well. I hope both drugs succeed.
From an investment standpoint, I've looked at RLFTF but the lack of a meaningful pipeline (as you pointed out LL has), and the amount of outstanding shares made it a non starter for me. But, that doesn't mean it wont be a good investment. I've just exceeded my limit for speculative investments.